Head-To-Head Comparison: Tactile Systems Technology (TCMD) and Its Competitors

Tactile Systems Technology (NASDAQ:TCMD) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its rivals? We will compare Tactile Systems Technology to similar businesses based on the strength of its dividends, risk, institutional ownership, earnings, profitability, analyst recommendations and valuation.

Insider and Institutional Ownership

83.4% of Tactile Systems Technology shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 2.1% of Tactile Systems Technology shares are held by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

Tactile Systems Technology has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500. Comparatively, Tactile Systems Technology’s rivals have a beta of 5.49, indicating that their average stock price is 449% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Tactile Systems Technology and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tactile Systems Technology	0	2	4	0	2.67
Tactile Systems Technology Competitors	4252	10480	18203	824	2.46

Tactile Systems Technology presently has a consensus price target of $37.60, suggesting a potential upside of 63.19%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 25.50%. Given Tactile Systems Technology’s stronger consensus rating and higher probable upside, equities analysts clearly believe Tactile Systems Technology is more favorable than its rivals.

Profitability

This table compares Tactile Systems Technology and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tactile Systems Technology	7.10%	11.49%	9.17%
Tactile Systems Technology Competitors	-278.23%	-150.07%	-21.87%

Earnings & Valuation

This table compares Tactile Systems Technology and its rivals revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Tactile Systems Technology	$329.52 million	$19.09 million	21.33
Tactile Systems Technology Competitors	$1.88 billion	$139.14 million	10.75

Tactile Systems Technology’s rivals have higher revenue and earnings than Tactile Systems Technology. Tactile Systems Technology is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Summary

Tactile Systems Technology beats its rivals on 8 of the 13 factors compared.

About Tactile Systems Technology

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.